Of note, all approaches focusing on epithelial markers for CTC detection are potentially vulnerable because cancer cells may undergo epithelial–mesenchymal transition (EMT) which is characterized by downregulation of epithelial markers, including cytokeratins and EpCAM, leading to dissemination of tumor cells away from the primary tumor into the circulation [23,24]. The gene discussed is EPCAM; the disease is neoplasm.